Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Healthcare Biotechnology
Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Vaxil Bio Ltd
Bullboard Posts
User Avatar Image
(262)
•••
Comment by reeJoeyon Mar 13, 2020 6:48pm
95 Views
Post# 30806516

RE:VXL and Trump

RE:VXL and TrumpThe idiot is the poster boy for VXL and the screaming need for its vaccine and dispenser.  Read about what the moron did at today's dog and pony show--from Washington Post:

Trump shook hands, patted backs and touched the mic 31 times during news conference

President Trump at a Friday news conference touted the work of his administration’s health experts on coronavirus, even as he ignored their public health advice.

Trump shook hands, patted backs and touched the microphone at the White House podium at least 31 times at the Rose Garden event, the sort of behaviors health experts and the Centers for Disease Control and Prevention have advised against to prevent the spread of the virus.

When the last executive had finished speaking, Trump offered him a handshake.

“We’ll practice that,” LHC Group Executive Vice President Bruce Greenstein said, offering Trump an elbow bump instead.

“Okay, I like that, that’s good,” Trump said, before adjusting the microphone with his hand yet again.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities